CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Recommended from our members
Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator’s choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
Author
Barta Stefan K
Conlon Kevin
+12 more
Delioukina Maria L
Dwyer Karen M
Fields Paul
Grebennik Dmitri O
Hermine Olivier
Horwitz Steven M
Kurman Michael R
Meniane Jean Côme
Phillips Adrienne Alise
Ramos Juan Carlos
Saunders Andrew
Taylor Graham
Publication venue
Publication date
20/05/2014
Field of study
No full text
University of Miami: Scholarship Miami
Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator’s choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL).
Author
Adrienne Alise Phillips
Andrew Saunders
+12 more
Dmitri O. Grebennik
Graham Taylor
Jean Côme Meniane
Juan Carlos Ramos
Karen M. Dwyer
Kevin Conlon
Maria L. Delioukina
Michael R. Kurman
Olivier Hermine
Paul Fields
Stefan K. Barta
Steven M. Horwitz
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref